Find your dream job now!

Click on Location links to filter by Job Title & Location.
Click on Company links to filter by Company & Location.
For exact match, enclose search terms in "double quotes".

Keywords: Head of Global Public Affairs and Advocacy Oncology, Location: Paris

Page: 1

Head of Global Public Affairs and Advocacy Oncology

Title: Head of Global Public Affairs and Advocacy Oncology Company: Ipsen Pharma (SAS) About Ipsen: Ipsen... strategies to be fully embedded in the company Brand plans. The Head of Global Public Affairs and Advocacy for Oncology...

Company: Ipsen
Location: Paris
Posted Date: 29 May 2025

Head of Global Public Affairs and Advocacy Neuroscience

Title: Head of Global Public Affairs and Advocacy Neuroscience Company: Ipsen Pharma (SAS) About Ipsen: Ipsen... to join our team as the Head of Global Public Affairs and Advocacy for Neurosciences. This role is crucial in shaping healthcare...

Company: Ipsen
Location: Paris
Posted Date: 29 May 2025

Head of Global Public Affairs and Advocacy Rare Diseases

Title: Head of Global Public Affairs and Advocacy Rare Diseases Company: Ipsen Pharma (SAS) About Ipsen: Ipsen... Affairs team with 3 key new Global Public Affairs and Advocacy leadership roles in Rare Diseases, Oncology, and Neurotoxins...

Company: Ipsen
Location: Paris
Posted Date: 29 May 2025

Global Head of Communications, Therapeutic Area Oncology

), collaborating with global functions including Asset teams, medical affairs, market access & public affairs. The Global Head...Title: Global Head of Communications, Therapeutic Area Oncology Company: Ipsen Pharma (SAS) About Ipsen: Ipsen...

Company: Ipsen
Location: Paris
Posted Date: 08 Jul 2025

Global Head of Communications, Therapeutic Area Neurosciences

), collaborating with global functions including asset teams, medical affairs, market access & public affairs. The Global Head...Title: Global Head of Communications, Therapeutic Area Neurosciences Company: Ipsen Pharma (SAS) About Ipsen...

Company: Ipsen
Location: Paris
Posted Date: 09 Jul 2025